Welcome to our dedicated page for GREEN STAR PRODUCTS news (Ticker: GSPI), a resource for investors and traders seeking the latest updates and insights on GREEN STAR PRODUCTS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GREEN STAR PRODUCTS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GREEN STAR PRODUCTS's position in the market.
Green Star Products, Inc. (OTC: GSPI) issued a Force Majeure on December 28, 2021, to cancel the issuance of 30 million preferred shares to Biotech Research, LLC. The company faced significant disruptions in international trade due to pandemic-related restrictions, preventing the distribution of its product, Viro Spectrum Shield, in South America. The preferred shares, which represent voting rights but have no monetary value, will be returned to the treasury. GSPI is currently rebranding VSS to comply with FTC demands and is establishing a distribution network for its rebranded anti-viral supplement.
Green Star Products, Inc. (GSPI) has announced that its president, Kristy Hunt, released positive efficacy data for its COVID-19 product, Viro Spectrum Shield (VSS). Conducted by MRIGlobal, the study showed 99.9% efficacy as a pre-treatment and 93% efficacy after infection, with no reported toxicity. Hunt is initiating a humanitarian program to distribute thousands of VSS bottles to affected countries at no cost. The product is classified as a dietary supplement, allowing it to bypass FDA approval.
Green Star Products, Inc. (GSPI) has signed a contract with A&P Distributors LLC to distribute its antiviral product, Viro Spectrum Shield (VSS), across 23 Pacific Rim countries. A&P's distribution network includes over 93 major companies, including military facilities. VSS has shown promising results in in vitro testing against multiple viruses, including COVID-19. Human trials indicated rapid recovery from symptoms for volunteers taking VSS, with no reported side effects. GSPI emphasizes its commitment to improving public health with environmentally friendly products.
Green Star Products, Inc. (GSPI) announces the appointment of Kristy Hunt as its new President, succeeding Joseph LaStella, who is stepping down at age 81. Hunt brings extensive experience from past projects including operations for the Army, Navy, and Air Force, and strategic planning at major companies. LaStella will assist Hunt in transitioning leadership. Hunt aims to leverage existing technology for improved cash flow. The company remains focused on developing environmentally friendly products. For more details, visit gspiusa.com.
Green Star Products, Inc. (GSPI) has secured sufficient shareholder votes to finalize its COVID-19 contract with Biotech Research, LLC, with over 90% approval reported. This milestone allows GSPI to proceed with an exclusive distribution agreement for Viro Spectrum Shield (VSS), a product demonstrated to be 99.9% effective against COVID-19 in vitro. The 2021 Special Shareholders Meeting is set for March 3, 2021. Despite the challenges posed by the pandemic, GSPI is prioritizing the distribution of VSS, which shows promise in combating viral infections.
FAQ
What is the current stock price of GREEN STAR PRODUCTS (GSPI)?
What is the market cap of GREEN STAR PRODUCTS (GSPI)?
